GlassScriptPhysician profile
Brittany A Bindon
NPI 1811346398
$1,070.40
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.13 · 2021: $635 · 2022: $414.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $465.21 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $223.05 | 2021-2022 | |
| Genzyme Corporation | $164.25 | 2022 | |
| Glaxosmithkline, LLC. | $126.38 | 2020-2021 | |
| Genentech USA, INC. | $28.33 | 2022 | |
| Pharming Healthcare, INC. | $25.96 | 2021 | |
| Biocryst US Sales Co., LLC | $21.04 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.18 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Bindon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.